Skip to main content

Table 1 Sample characteristics of the studies included in the meta-analysis

From: Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis

References N Participants Nation Mean age ±SD (y) Female (%) Hypertension (%) DM (%) CVA (%) CVD (%)
Arnau et al. 2016 [6] 315 Outpatients Spain-Eu 82 ± 5 191 (61) 62 (20)
Brown et al. 2015 [7] 413 General population USA-Am 73 ± 1 248 (60) 189 (46) 43 (10) 28 (7) 63 (15)
Cesari et al. 2008 [8] 200 General population IT-Eu 86 ± 1 223 (67) 246 (73) 92 (27) 15 (4) 40 (12)
Cesari et al. 2013 [9] 335 Outpatients IT-Eu 74 ± 6 200 (100) 166 (83) 33 (17) 2 (1) 40 (20)
Chiarantini et al. 2010 [10] 157 Hospitalized IT-Eu 80 ± 1 79 (50) 52 (33) 77 (49)
Corsonello et al. 2012 [11] 506 Hospitalized IT-Eu 80 ± 6 231 (46) 357 (71) 130 (26) 66 (13) 149 (29)
Ensrud et al. 2016 [12] 1495 General population USA-Am 88 ± 3 1495 (100) 985 (66) 219 (15) 194 (13) 373 (25)
Greene et al. 2014 [13] 1627 General populationa USA-Am 49 ± 8 561 (34)
Kim et al. 2016 [14] 560 General population Korea-As 74 ± 7 274 (49) 256 (46) 49 (9) 87 (16) 87 (16)
Lai et al. 2014 [15] 294 Outpatients USA-Am 57 ± 10 100 (34) 123 (42) 85 (29) 4 (1) 17 (6)
Legrand et al. 2014 [16] 560 General population BE-Eu 85 ± 4 351 (63) 393 (70) 104 (19) 46 (8) 140 (25)
Minneci et al. 2015 [17] 561 General population IT-Eu 73 ± 1 323 (58)
Rolland et al. 2006 [18] 7250 General population FR-Eu 81 ± 4 7250 (100) 3429 (47) 420 (6) 210 (3) 3495 (48)
Stenholm et al. 2016 [19] 996 General population IT-Eu 75 ± 7 558 (56) 630 (63) 123 (12) 57 (6) 81 (8)
Tadjibaev et al. 2014 [20] 611 General population RUS-Eu 75 ± 6 441 (72) 567 (93) 87 (14) 91 (15) 484 (79)
Verghese et al. 2012 [21] 567 General population USA-Am 80 ± 5 345 (61) 355 (63) 93 (16) 56 (10) 69 (12)
Volpato et al. 2011 [22] 87 Hospitalized IT-Eu 77 ± 6 43 (49) 77 (89) 21 (24) 11 (13) 17 (20)
  1. SD standard deviation, DM diabetes mellitus, CVA cerebrovascular accident, CVD cardiovascular disease, y years, Am America, Eu Europe, As Asia, IT Italy, BE Belgium, FR France, RUS Russia
  2. aInjection drug user